Gene-editing startup Tome Biosciences buys Replace Therapeutics
The formal launch of Tome and its buyout of Replace Therapeutics come just as regulators in the US and Europe have approved the first gene-editing drug.
Stay updated with breaking news from Andreessen Horwitz. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The formal launch of Tome and its buyout of Replace Therapeutics come just as regulators in the US and Europe have approved the first gene-editing drug.
Starco Brands, Inc. (the "Company" or "Starco Brands") , developer and acquirer of behavior-changing technologies and brands that spark excitement in the everyday, today reported financial results for its third fiscal quarter and first nine months...
Starco Brands, Inc. , developer and acquirer of behavior-changing technologies and brands that spark excitement in the everyday, today provided a business update and announced partial guidance for...
The CFPB forced LendUp to halt on making new loans and collecting on certain outstanding loans, as well as to pay a penalty to resolve a Sept. 2016 lawsuit.
Today, the Consumer Financial Protection Bureau (CFPB) announced that LendUp Loans has agreed to halt making any new loans and collecting on certain outstanding loans, as well as to pay a penalty, to resolve a September 2021 lawsuit alleging that it continued to engage in illegal and deceptive marketing in violation of a 2016 CFPB order. The lawsuit also accuses LendUp of violating fair lending regulations.